These results demonstrated that AKT3 is one direct target of miR-145 in ESCC, and miR-145 can inhibit PI3K/AKT signaling pathway by directly down-regulating AKT3. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.